PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,771.00
Ask: 1,771.50
Change: -8.50 (-0.48%)
Spread: 0.50 (0.028%)
Open: 1,773.50
High: 1,779.00
Low: 1,764.50
Prev. Close: 1,783.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET COMMENT: Stocks Seen Lower; Ted Baker To Meet Forecasts

Fri, 12th Jun 2015 06:31

LONDON (Alliance News) - London share prices are set to open lower Friday, as confidence in a deal emerging from the Greek debt negotiations took a hit late Thursday, with stock indices across Europe giving back almost half of their earlier gains late in trading.

IG says futures indicate the FTSE 100 to open 25 points lower at 6,821.6. The index closed up 0.2% at 6,846.74 on Thursday, having reached a peak of 6,870.19.

The International Monetary Fund's technical team left bailout talks with Greece in Brussels and returned to Washington with the sides "well away from an agreement", IMF spokesman Gerry Rice said Thursday.

"There are major differences between us in most key areas," according to Rice. "There has been no progress in narrowing these differences recently."

The IMF spokesman noted the "urgency" of the talks, but he added there is "no real schedule here" for negotiations. "The IMF never leaves the table," Rice said. "We remain engaged, but the ball is very much in Greece's court right now."

CMC Markets UK chief market analyst Michael Hewson comments: "The logjam appears to revolve around pension and labour market reform, which Greece remains unwilling to compromise on, and when looking at the demonstrations that took place back in Athens yesterday it?s not hard to see why."

"Even if Greece does compromise on the issues the IMF wants change on, there is no guarantee that they would be able to implement them and therein lies the rub," writes Hewson.

Despite the IMF's leaving, Greece's State Minister Alekos Flabouraris was optimistic talking to Greek television ERT, Reuters reported Friday.

"I hope [a deal] will come very soon, on June 18, when the Eurogroup takes place," said Flabouraris.

Lloyds Bank economist Rhys Herbert agrees: "We treat the June 18 [Eurogroup meeting] as the deal-maker date as the meetings over the past three days confirmed the strong political will for an agreement as soon as possible."

Wall Street ended higher Thursday. The DJIA and the S&P 500 ended up 0.2% and the Nasdaq Composite closed up 0.1%.

In Asia on Friday, the Japanese Nikkei 225 closed up 0.1%. Meanwhile, the Hang Seng trades up 0.6% and the Shanghai Composite is up 1.0%.

Japan's industrial production climbed more than initially estimated in April, latest figures from the Ministry of Economy, Trade and Industry showed Friday. Industrial production rose a seasonally adjusted 1.2% month-over-month in April, revised up from a 1.0% gain in the flash data. It was the first increase in three months. In March, production had fallen 0.8%.

In the corporate front, fashion retailer Ted Baker Friday said it is on track to meet expectations for its full year following a strong start, with revenue up 24.2% in the eighteen weeks from the beginning of February to June 6.

Retail sales during the period were up 18.9%, or 18.1% at constant currency, the company said. E-commerce sales rose 46.9%, driven by further growth in the UK and a strong performance from Ted Baker's US site, as well as a contribution from its new Canadian site launched at the end of 2014.

GlaxoSmithKline said the Pulmonary Allergy Drugs Advisory Committee of the US Food and Drug Administration voted unanimously that efficacy and safety data for mepolizumab supported its approval for adults aged 18 or older with severe asthma.

Meanwhile, Royal Dutch Shell has notified Ukraine that it will pull out of a shale gas exploration project in the east of the country, the Financial Times reported Thursday, as a result of the ongoing conflict in the region.

Insiders cited heightened geopolitical risk and sharp drop in global oil prices, which has made shale gas exploration projects less attractive, the report says.

In a light economic calendar Friday, eurozone industrial production is due at 1000 BST. In the US, producer price index is due at 1330 BST, while Reuters/Michigan consumer sentiment index is due at 1500 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.